首页|基于生物信息学探索let-7c-5p通过靶向OLFM4参与支气管哮喘疾病进展研究

基于生物信息学探索let-7c-5p通过靶向OLFM4参与支气管哮喘疾病进展研究

扫码查看
目的 基于生物信息学探索let-7c-5p通过靶向OLFM4参与支气管哮喘疾病进展。方法 选取基因表达公共数据库(GEO)中芯片数据集GSE207751和GEO222894,采用R软件的"Limma"和"DESeq2"软件包分析2个数据集中的差异表达基因(DEGs)和差异miRNA。利用hclust函数进行WCGNA分析。应用"ClusterProfiler"软件包进行基因本体(GO)功能注释富集分析和京都基因与基因组百科全书信号通路富集分析,STRING数据库建立蛋白互作网络(PPI网络),Cytoscape筛选严重哮喘患者的核心基因。miRWalk、miR-Base和miRTarBase数据库用于靶基因的miRNA预测。结果 分析获得80个DEGs,包括上调的OLFM4,进行 WCGNA分析后发现和哮喘严重程度相关的Darked模块基因24个,之后进行PPI网格构建和mRNA-miRNA预测筛选出4个核心上调基因(包括OLFM4)和6个miRNA(包括hsa-let-7c-5p)。分析获得98个差异表达miRNA,其中上调5个,下调93个。进行轻度哮喘患者和重度哮喘患者差异miRNA交叉分析发现,let-7c-5p在轻度哮喘患者和重度哮喘患者中表达下调。结论 研究多重验证了在哮喘患者中,let-7c-5p通过调控OLFM4影响哮喘的气道炎症和气道重塑,参与哮喘疾病进展,有利于了解哮喘疾病状态进展的潜在分子机制,同时验证了 let-7c-5p成为哮喘潜在生物标志物的潜力,为进一步研究哮喘疾病进展提供理论基础。
Exploring the involvement of let-7c-5p in the progression of bronchial asthma by targeting OLFM based on bioinformatics
Objective To explore the involvement of let-7c-5p in the progression of bronchial asthma by targeting OLFM based on bioinformatics.Methods The microarray data sets GSE207751 and GEO222894 in the Gene Expression Omnibus(GEO)database were selected.The"imma"and"DESeq2"software packages of R software were used to analyze the differentially expressed genes(DEGs)and differentially expressed miRNAs in the two data sets.WCGNA analysis was performed using the hclust function.The"ClusterProfil-er"software package was used for gene ontology(GO)functional annotation enrichment analysis and Kyoto Encyclopedia of Genes and Genomes signal pathway enrichment analysis.The STRING database was used to establish a protein interaction network(PPI network),and Cytoscape was used to screen the core genes of pa-tients with severe asthma.The miRWalk,miRBase and miRTarBase databases were used for miRNA predic-tion of target genes.Results A total of 80 DEGS were obtained,including up-regulated OLFM4.After WCG-NA analysis,24 Darked module genes related to the severity of asthma were found.Four core up-regulated genes(including OLFM4)and six miRNAs(including hsa-let-7c-5p)were screened out by PPI grid construc-tion and mRNA-miRNA prediction.A total of 98 differentially expressed miRNAs were obtained,of which five were up-regulated and 93 were down-regulated.Cross-analysis of differential miRNAs between mild asth-ma patients and severe asthma patients showed that let-7c-5p was down-regulated in mild asthma patients and severe asthma patients.Conclusion This study has repeatedly verified that let-7c-5p affects airway inflamma-tion and airway remodeling of asthma by regulating OLFM4 in asthma patients,and participates in the pro-gression of asthma disease,which is conducive to understanding the potential molecular mechanism of the pro-gression of asthma disease.At the same time,it has verified the potential of let-7c-5p as a potential biomarker for asthma,which provides a theoretical basis for further study of the progression of asthma disease.

Let-7c-5pOLFM4Bronchial asthmaDisease progressionBiomarkers

刘锡娇、黎友伦

展开 >

重庆医科大学附属璧山医院呼吸与危重症医学科,重庆 402760

重庆医科大学附属第一医院,重庆 400016

let-7c-5p OLFM4 支气管哮喘 疾病进展 生物标志物

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(11)